264 related articles for article (PubMed ID: 30066297)
1. Vimentin, osteocalcin and osteonectin expression in canine primary bone tumors: diagnostic and prognostic implications.
Amaral CB; Leite JDS; Fonseca ABM; Ferreira AMR
Mol Biol Rep; 2018 Oct; 45(5):1289-1296. PubMed ID: 30066297
[TBL] [Abstract][Full Text] [Related]
2. Osteocalcin and Osteonectin Expression in Canine Osteosarcoma.
Wehrle-Martinez AS; Dittmer KE; Aberdein D; Thompson KG
Vet Pathol; 2016 Jul; 53(4):781-7. PubMed ID: 26926085
[TBL] [Abstract][Full Text] [Related]
3. Expression of connexins in normal and neoplastic canine bone tissue.
Sanches DS; Pires CG; Fukumasu H; Cogliati B; Matsuzaki P; Chaible LM; Torres LN; Ferrigno CR; Dagli ML
Vet Pathol; 2009 Sep; 46(5):846-59. PubMed ID: 19429987
[TBL] [Abstract][Full Text] [Related]
4. The impact of osteonectin for differential diagnosis of osteogenic bone tumors: an immunohistochemical and in situ hybridization approach.
Park YK; Yang MH; Park HR
Skeletal Radiol; 1996 Jan; 25(1):13-7. PubMed ID: 8717113
[TBL] [Abstract][Full Text] [Related]
5. Use of alkaline phosphatase staining to differentiate canine osteosarcoma from other vimentin-positive tumors.
Barger A; Graca R; Bailey K; Messick J; de Lorimier LP; Fan T; Hoffmann W
Vet Pathol; 2005 Mar; 42(2):161-5. PubMed ID: 15753469
[TBL] [Abstract][Full Text] [Related]
6. An in vivo/in vitro experimental model system for the study of human osteosarcoma: canine osteosarcoma cells (COS31) which retain osteoblastic and metastatic properties in nude mice.
Shoieb AM; Hahn KA; Barnhill MA
In Vivo; 1998; 12(5):463-72. PubMed ID: 9827352
[TBL] [Abstract][Full Text] [Related]
7. Osteonectin in osteosarcomas: a marker for differential diagnosis and/or prognosis?
Wuisman P; Roessner A; Bosse A; Ueda Y; Winkelmann W; Enneking WF
Ann Oncol; 1992 Apr; 3 Suppl 2():S33-5. PubMed ID: 1622861
[TBL] [Abstract][Full Text] [Related]
8. Osteocalcin and osteonectin immunoreactivity in extraskeletal osteosarcoma: a study of 28 cases.
Fanburg-Smith JC; Bratthauer GL; Miettinen M
Hum Pathol; 1999 Jan; 30(1):32-8. PubMed ID: 9923924
[TBL] [Abstract][Full Text] [Related]
9. Role of immunohistochemical cyclo-oxygenase-2 (COX-2) and osteocalcin in differentiating between osteoblastomas and osteosarcomas.
El-Badawi ZH; Muhammad EM; Noaman HH
Malays J Pathol; 2012 Jun; 34(1):15-23. PubMed ID: 22870593
[TBL] [Abstract][Full Text] [Related]
10. HES1, a target of Notch signaling, is elevated in canine osteosarcoma, but reduced in the most aggressive tumors.
Dailey DD; Anfinsen KP; Pfaff LE; Ehrhart EJ; Charles JB; Bønsdorff TB; Thamm DH; Powers BE; Jonasdottir TJ; Duval DL
BMC Vet Res; 2013 Jul; 9():130. PubMed ID: 23816051
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2 expression in canine appendicular osteosarcomas.
Mullins MN; Lana SE; Dernell WS; Ogilvie GK; Withrow SJ; Ehrhart EJ
J Vet Intern Med; 2004; 18(6):859-65. PubMed ID: 15638270
[TBL] [Abstract][Full Text] [Related]
12. The impact of osteonectin for differential diagnosis of bone tumors. An immunohistochemical approach.
Bosse A; Vollmer E; Böcker W; Roessner A; Wuisman P; Jones D; Fisher LW
Pathol Res Pract; 1990 Oct; 186(5):651-7. PubMed ID: 2287591
[TBL] [Abstract][Full Text] [Related]
13. Analysis of gene expression of prostaglandin EP4 receptor in canine osteosarcoma.
Musser ML; Viall AK; Phillips RL; Hostetter JM; Johannes CM
Can J Vet Res; 2021 Jan; 85(1):68-71. PubMed ID: 33390656
[TBL] [Abstract][Full Text] [Related]
14. [Immunohistochemical localization of bone Gla protein and osteonectin in normal human bone and cartilage tissues, and in osteosarcomas and chondrosarcomas].
Chiba H; Matsuyama T
Nihon Seikeigeka Gakkai Zasshi; 1993 May; 67(5):463-72. PubMed ID: 8336066
[TBL] [Abstract][Full Text] [Related]
15. The use of alkaline phosphatase and runx2 to distinguish osteosarcoma from other common malignant primary bone tumors in dogs.
Barger A; Baker K; Driskell E; Sander W; Roady P; Berry M; Schnelle A; Fan TM
Vet Pathol; 2022 May; 59(3):427-432. PubMed ID: 35253545
[TBL] [Abstract][Full Text] [Related]
16. Multipotential osteosarcoma with various mesenchymal differentiations in a young dog.
Hoenerhoff MJ; Kiupel M; Rosenstein D; Pool RR
Vet Pathol; 2004 May; 41(3):264-8. PubMed ID: 15133175
[TBL] [Abstract][Full Text] [Related]
17. Fibroblastic osteosarcoma with epithelioid and squamous differentiation in a dog.
Jenkins TL; Agnew D; Rissi DR
J Vet Diagn Invest; 2018 Jul; 30(4):593-597. PubMed ID: 29629646
[TBL] [Abstract][Full Text] [Related]
18. The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomas.
Machado I; Navarro S; Picci P; Llombart-Bosch A
Pathol Res Pract; 2016 Sep; 212(9):811-6. PubMed ID: 27465835
[TBL] [Abstract][Full Text] [Related]
19. Prognostic and predictive biomarkers of canine osteosarcoma.
Selvarajah GT; Kirpensteijn J
Vet J; 2010 Jul; 185(1):28-35. PubMed ID: 20493743
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological relevance of tumour grading in canine osteosarcoma.
Loukopoulos P; Robinson WF
J Comp Pathol; 2007 Jan; 136(1):65-73. PubMed ID: 17270206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
